InflaRx Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

3/13/2026
Impact: -75
Healthcare

InflaRx N.V. (NASDAQ: IFRX) has received a notice from Nasdaq indicating that its ordinary shares have closed below the minimum bid price requirement of $1.00 per share for the last thirty consecutive business days. This deficiency is in accordance with Nasdaq Listing Rule 5450(a)(1), which governs the minimum bid price for continued listing. The notice was dated March 11, 2026.

AI summary, not financial advice

Share: